Calendar

May
11
Tue
2021
Cancer Early Detection Seminar Series - Michael Berger, Ph.D. @ Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series – Michael Berger, Ph.D.
May 11 @ 11:00 am – 12:00 pm Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series - Michael Berger, Ph.D. @ Zoom - See Description for Zoom Link

CEDSS: “Building a Scalable Clinical Genomics Program: How tumor, normal, and plasma DNA sequencing are informing cancer care, cancer risk, and cancer detection”

 

Michael Berger, Ph.D.

Elizabeth and Felix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

 

Zoom Details
Meeting URL: https://stanford.zoom.us/s/92559505314
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Meeting ID: 925 5950 5314
Passcode: 418727

11:00am – 12:00pm Seminar & Discussion
RSVP Here

 

ABSTRACT
Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of oncogenomic mutations that can be targeted therapeutically. To accelerate enrollment to clinical trials of molecularly targeted agents and guide treatment selection, we have established a center-wide, prospective clinical sequencing program at Memorial Sloan Kettering Cancer Center using a custom, paired tumor-blood normal sequencing assay (MSK-IMPACT), which we have used to profile more than 50,000 patients with solid tumors. Yet beyond just the characterization of tumor-specific alterations, the inclusion of blood DNA has readily enabled the identification of germline risk alleles and somatic mutations associated with clonal hematopoiesis. To complement this approach, we have also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for cancer detection, surveillance, and treatment selection and monitoring. In my talk, I will describe the prevalence of somatic and germline genomic alterations in a real-world population, the clinical benefits of cfDNA assessment, and how clonal hematopoiesis can inform cancer risk and confound liquid biopsy approaches to cancer detection.

 

ABOUT
Michael Berger, PhD, holds the Elizabeth and Felix Rohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center, a multidisciplinary initiative to promote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. He is also an Associate Attending Geneticist in the Department of Pathology with expertise in cancer genomics, computational biology, and high-throughput DNA sequencing technology. His laboratory is developing experimental and computational methods to characterize the genetic makeup of individual cancers and identify genomic biomarkers of drug response and resistance. As Scientific Director of Clinical NGS in the Molecular Diagnostics Service, he oversees the development and bioinformatics associated with clinical sequencing assays, and he helped lead the development and implementation of MSK-IMPACT, a comprehensive FDA-authorized tumor sequencing panel that been used to profile more than 60,000 tumors from advanced cancer patients at MSK. The resulting data have enabled the characterization of somatic and germline biomarkers across many cancer types and the identification of mutations associated with clonal hematopoiesis. Dr. Berger also led the development of a clinically validated plasma cell-free DNA assay, MSK-ACCESS, which his laboratory is using to explore tumor evolution, acquired drug resistance, and occult metastatic disease. He received his Bachelor’s Degree in Physics from Princeton University and his Ph.D. in Biophysics from Harvard University.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by: The Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Jun
3
Thu
2021
IMMERS - Stanford Medical Mixed Reality Panel Discussion Series @ Zoom
IMMERS – Stanford Medical Mixed Reality Panel Discussion Series
Jun 3 @ 9:00 am – 10:30 am Zoom
IMMERS - Stanford Medical Mixed Reality Panel Discussion Series @ Zoom

Join us for a panel on Behavioral XR on Thursday, June 3rd from 9:00 – 10:30 am PDT.  The event will start with a one-hour panel discussion featuring Dr. Elizabeth McMahon, a psychologist with a private practice in California; Sarah Hill of Healium, a company developing XR apps for mental fitness based in Missouri; Christian Angern of Sympatient, a company developing VR for anxiety therapy based in Germany; and Marguerite Manteau-Rao of Penumbra, a medical device company based in California.  This panel will be moderated by Dr. Walter Greenleaf of Stanford’s Virtual Human Interaction Lab (VHIL) and Dr. Christoph Leuze of the Stanford Medical Mixed Reality (SMMR) program.  Immediately following the panel discussion, you are also invited to a 30-minute interactive session with the panelists where questions and ideas can be explored in real time.

 

Register here to save your place now!  After registering, you will receive a confirmation email containing information about joining the meeting.

 

Please visit this page to subscribe to our events mailing list.

 

Sponsored by Stanford Medical Mixed Reality (SMMR)

Sep
10
Fri
2021
CME Grand Rounds Sanjiv Sam Gambhir Lectureship - Simon Cherry, PhD @ LKSC 101/102 & Zoom - See Description for Zoom Link
CME Grand Rounds Sanjiv Sam Gambhir Lectureship – Simon Cherry, PhD
Sep 10 @ 12:00 pm – 1:00 pm LKSC 101/102 & Zoom - See Description for Zoom Link
CME Grand Rounds Sanjiv Sam Gambhir Lectureship - Simon Cherry, PhD @ LKSC 101/102 & Zoom - See Description for Zoom Link

CME Grand Rounds Sanjiv Sam Gambhir Lectureship – “Imaging at the Speed of Light:  Innovations in Positron Emission Tomography”

 

Simon R. Cherry, PhD
Professor
Biomedical Engineering & Radiology
UC Davis

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT

Positron emission tomography (PET) allows for sensitive and quantitative measurement of physiology, metabolism and molecular targets noninvasively in the human body.  However, typical clinical PET scanners capture less than 1% of the available signal produced in the body.  PET scanners also are not currently capable of precisely determining the location at which a particular decay occurs. These limitations present opportunities for further innovation that ultimately will impact molecular imaging research and diagnostic imaging with PET.  This presentation focuses on 1) total-body PET imaging which greatly improves signal collection, allowing radiotracer kinetics to be assessed across the entire human body for the first time, and 2) the development of detector technologies that have a timing precision of ~ 30 picoseconds, enabling direct localization of radiotracer decays without tomographic reconstruction.

 

BIO

Simon R. Cherry, Ph.D.  received his B.Sc.(Hons) in Physics with Astronomy from University College London in 1986 and a Ph.D. in Medical Physics from the Institute of Cancer Research, University of London in 1989.  After a postdoctoral fellowship at UCLA, he joined the faculty in the Department of Molecular and Medical Pharmacology, also at UCLA, in 1993. In 2001, Dr. Cherry joined UC Davis and established the Center for Molecular and Genomic Imaging, which he directed from 2004-2016. Currently Dr. Cherry is Distinguished Professor in the Departments of Biomedical Engineering and Radiology at UC Davis.

Dr. Cherry’s research interests center around biomedical imaging and in particular the development and application of in vivo molecular imaging systems.  His major accomplishments have been in developing systems for positron emission tomography (PET), in particular the invention of the microPET technology that was subsequently widely adopted in academia and industry and as co-leader of the EXPLORER consortium which has developed the world’s first total-body PET scanner.  He also has contributed to detector technology innovations for PET, conducted early biomedical studies using Cerenkov luminescence, and developed the first proof-of-concept hybrid PET/MRI (magnetic resonance imaging) systems.

Dr. Cherry is a founding member of the Society of Molecular Imaging and an elected fellow of six professional societies, including the Institute for Electronic and Electrical Engineers (IEEE) and the Biomedical Engineering Society (BMES). He served as Editor-in-Chief of the journal Physics in Medicine and Biology from 2011-2020. Dr. Cherry received the Academy of Molecular Imaging Distinguished Basic Scientist Award (2007), the Society for Molecular Imaging Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Award (2016).   In 2016, he was elected as a member of the National Academy of Engineering and in 2017 he was elected to the National Academy of Inventors.  Dr. Cherry is the author of more than 240 peer-reviewed journal articles, review articles and book chapters in the field of biomedical imaging. He is also lead author of the widely-used textbook “Physics in Nuclear Medicine”.

Sep
24
Fri
2021
CME Grand Rounds Diversity Lectureship - Jennifer L. Eberhardt, PhD @ Zoom - See Description for Zoom Link
CME Grand Rounds Diversity Lectureship – Jennifer L. Eberhardt, PhD
Sep 24 @ 12:00 pm – 1:00 pm Zoom - See Description for Zoom Link
CME Grand Rounds Diversity Lectureship - Jennifer L. Eberhardt, PhD @ Zoom - See Description for Zoom Link

CME Grand Rounds Diversity Lectureship – Topic: TBD

 

Jennifer L. Eberhardt, PhD
Professor
Psychology
Stanford University

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT
Coming soon!

 

BIO
Coming soon!

Oct
6
Wed
2021
Early Detection of Cancer Conference @ Virtual Event
Early Detection of Cancer Conference
Oct 6 – Oct 8 all-day Virtual Event
Early Detection of Cancer Conference @ Virtual Event

Cancer Research UK, OHSU Knight Cancer Institute and the Canary Center at Stanford, present the Early Detection of Cancer Conference series. The annual Conference brings together experts in early detection from multiple disciplines to share ground breaking research and progress in the field.

The Conference is part of a long-term commitment to invest in early detection research, to understand the biology behind early stage cancers, find new detection and screening methods, and enhance uptake and accuracy of screening.

The 2021 conference will take place October 6-8 virtuallyFor more information visit the website: http://earlydetectionresearch.com/

Oct
8
Fri
2021
CME Grand Rounds - Christoph L. Lee, MD, MS, MBA @ Zoom - See Description for Zoom Link
CME Grand Rounds – Christoph L. Lee, MD, MS, MBA
Oct 8 @ 12:00 pm – 1:00 pm Zoom - See Description for Zoom Link
CME Grand Rounds - Christoph L. Lee, MD, MS, MBA @ Zoom - See Description for Zoom Link

CME Grand Rounds – “Community Based Partnered Research:  Revisiting a Critical Concept for Radiology”

 

Christoph L. Lee, MD, MS, MBA
Professor
Radiology
University of Washington

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT
Coming soon!

 

BIO
Coming soon!

Oct
12
Tue
2021
Cancer Early Detection Seminar Series - Azra Raza, MD @ Venue coming soon!
Cancer Early Detection Seminar Series – Azra Raza, MD
Oct 12 @ 11:00 am – 12:00 pm Venue coming soon!
Cancer Early Detection Seminar Series - Azra Raza, MD @ Venue coming soon!

CEDSS: The First Cell: A new model for cancer research and treatment

Azra Raza, M.D.
Chan Soon-Shiong Professor of Medicine
Director, Myelodysplastic Syndrome Center
Columbia University Medical Center

 

Location: Zoom
Meeting URL: https://stanford.zoom.us/s/99340345860
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Meeting ID: 993 4034 5860
Passcode: 711508

RSVP Here

 

ABSTRACT

Cancer research continues to be predicated on a 1970’s model of research and treatment. Despite half a century of intense research, we are failing spectacularly to improve the outcome for patients with advanced disease. Those who are cured continue to be treated mostly with the older strategies (surgery-chemo-radiation). Our contention is that the real solution to the cancer problem is to diagnose cancer early, at the stage of The First Cell. The rapidly evolving technologies are doing much in this area but need to be expanded. We study a pre-leukemic condition called myelodysplastic syndrome (MDS) with the hope that we can detect the first leukemia cells as the disease transforms to acute myeloid leukemia (AML). Towards this end, we have collected blood and bone marrow samples on MDS and AML patients since 1984. Today, our Tissue Repository has more than 60,000 samples. We propose novel methods to identify surrogate markers that can identify the First Cell through studying the serial samples of patients who evolve from MDS to AML.

 

ABOUT

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY.She started her research in Myelodisplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.

Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachussetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant and advisor and is the recipient of a number of awards.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by: The Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Oct
22
Fri
2021
CME Grand Rounds - Jocelyn D. Chertoff, MD, MS @ Zoom - See Description for Zoom Link
CME Grand Rounds – Jocelyn D. Chertoff, MD, MS
Oct 22 @ 12:00 pm – 1:00 pm Zoom - See Description for Zoom Link
CME Grand Rounds - Jocelyn D. Chertoff, MD, MS @ Zoom - See Description for Zoom Link

CME Grand Rounds – Topic: TBD

Jocelyn D. Chertoff, MD, MS
Professor
Radiology, Obstetrics & Gynecology
Chair, Radiology
Dartmouth Hitchcock Medical Center

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT
Coming soon!

 

BIO
Coming soon!

Nov
4
Thu
2021
CME Grand Rounds Etta K. Moskowitz Lectureship - Elizabeth Krupinski, PhD @ Zoom - See Description for Zoom Link
CME Grand Rounds Etta K. Moskowitz Lectureship – Elizabeth Krupinski, PhD
Nov 4 @ 5:30 pm – 6:30 pm Zoom - See Description for Zoom Link
CME Grand Rounds Etta K. Moskowitz Lectureship - Elizabeth Krupinski, PhD @ Zoom - See Description for Zoom Link

CME Grand Rounds Etta K. Moskowitz Lectureship – Topic: TBD

Elizabeth Krupinski, PhD
Professor & Vice Chair for Research
Radiology & Imaging Sciences
Emory University School of Medicine

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT
Coming soon!

 

BIO
Coming soon!

Nov
12
Fri
2021
CME Grand Rounds - Michael Gisondi, MD @ Zoom - See Description for Zoom Link
CME Grand Rounds – Michael Gisondi, MD
Nov 12 @ 12:00 pm – 1:00 pm Zoom - See Description for Zoom Link
CME Grand Rounds - Michael Gisondi, MD @ Zoom - See Description for Zoom Link

CME Grand Rounds – “Promote Your Academic Career Using Social Media”

Michael Gisondi, MD
Associate Professor & Vice Chair of Education
Emergency Medicine
Stanford University

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT
Coming soon!

 

BIO
Coming soon!